Brands and Their Owners
Welcome to the Brand page for “AAVANTI”, which is offered here for Biological treatment for use for clinical, medicinal and the therapeutic treatment of friedreich's ataxia and genetic disorders; biological preparations for the treatment of friedreich's ataxia and genetic disorders; biological preparations and biospecific reagents for use in immunotherapy for the treatment of friedreich's ataxia and genetic disorders; biological drugs for use for clinical, medicinal and therapeutic treatment of friedreich's ataxia; biological drugs for treatment of genetic diseases and friedreich's ataxia; biological drugs for use in treating friedreich's ataxia and autoimmunity disorders and diseases; gene therapy products, therapeutics for the treatment of friedreich's ataxia, autoimmune, immune system diseases and disorders; pharmaceutical preparations for human use for the treatment of friedreich's ataxia; therapeutic and medical diagnostic agents and preparations for use in therapies for friedreich's ataxia and autoimmunity; therapeutic and diagnostic agents, preparations and substances for medical purposes for targeting application to immunotherapies and therapeutic and diagnostic agents;.
Its status is currently believed to be active. Its class is unavailable. “AAVANTI” is believed to be currently owned by “AAVANTIBIO, INC.”
Owner: |
AAVANTIBIO, INC.
Owner Details |
---|---|
Description: |
Biological treatment for use for clinical, medicinal and the therapeutic treatment of Friedreich's Ataxia and genetic disorders; biological preparations for the treatment of Friedreich's Ataxia and genetic disorders; biological preparations and biospecific reagents for use in immunotherapy for the treatment of Friedreich's Ataxia and genetic disorders; biological drugs for use for clinical, medicinal and therapeutic treatment of Friedreich's Ataxia; biological drugs for treatment of genetic diseases and Friedreich's Ataxia; biological drugs for use in treating Friedreich's Ataxia and autoimmunity disorders and diseases; gene therapy products, therapeutics for the treatment of Friedreich's Ataxia, autoimmune, immune system diseases and disorders; pharmaceutical preparations for human use for the treatment of Friedreich's Ataxia; therapeutic and medical diagnostic agents and preparations for use in therapies for Friedreich's Ataxia and autoimmunity; therapeutic and diagnostic agents, preparations and substances for medical purposes for targeting application to immunotherapies and therapeutic and diagnostic agents;
|
Categories: | BIOLOGICAL TREATMENT USE |